Sign in

You're signed outSign in or to get full access.

Daryl Roberts

Director at AdvanSixAdvanSix
Board

About Daryl Roberts

Daryl Roberts was appointed as an independent director of AdvanSix (ASIX) on September 2, 2025, and currently serves as Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc. His credentials span global manufacturing operations, engineering, regulatory compliance, and health & safety leadership, with prior senior roles at Arkema S.A., Total, and Eastman Kodak, and service as a U.S. Army Chemical Corps officer in the reserves . He qualifies as independent under NYSE listing standards and the Company’s Corporate Governance Guidelines .

Past Roles

OrganizationRoleTenureCommittees/Impact
Arkema S.A.VP, Manufacturing, Technology & Regulatory Services2015–2018Led manufacturing/technology/regulatory functions
Arkema S.A.Senior Director, Manufacturing & Regulatory Services2012–2015Operations, manufacturing, regulatory leadership
Arkema/Total/Eastman KodakVarious manufacturing, HS&E, operations, engineering1998–2012Broad operations and safety experience
U.S. Army (Reserves)Officer – Chemical CorpsNot disclosedChemical safety/leadership background

External Roles

OrganizationRoleTenureNotes
DuPont de Nemours Inc.SVP & Chief Operations and Engineering Officer2018–presentExecutive leadership in global manufacturing and engineering

Board Governance

  • Board seat: Appointed September 2, 2025; Board expanded to nine members, eight independent .
  • Committee assignments: Compensation & Leadership Development (C&LD) and Health, Safety & Environmental (HS&E) .
  • Independence: Qualifies as independent under NYSE standards and Company guidelines .
  • Board leadership: Independent Chair (Todd D. Karran) with separated Chair/CEO roles .
  • Related-party safeguards: No arrangements/understandings; no family relationships; no transactions requiring disclosure under Item 404(a) at appointment . Company policy requires Nominating & Governance Committee review/approval of related party transactions >$100k; none since Jan 1, 2024 .

Fixed Compensation (Director Program Applicable to Roberts)

ComponentAmountVesting/Terms
Annual cash retainer (Board member)$90,000Paid in cash; eligible for DCP deferral
Equity grant (RSUs) – 2025 program$120,000Annual grant post-Annual Meeting; one-year vest
Chair retainers (if applicable)Audit Chair $20,000; C&LD Chair $15,000; HS&E Chair $15,000; Nominating & Governance Chair $15,000Only applicable if serving as Chair; Roberts is a member, not Chair
Independent Board Chair retainer$100,000Not applicable to Roberts
Deferred Compensation Plan (DCP)Eligible to defer up to 100% cash feesStock unit fund until ownership guideline met
  • Director stock ownership guidelines: Hold common stock equal to at least 5x annual base cash retainer (i.e., $450,000 based on 2024 retainer), with five years to comply; 100% of net shares from RSU vesting must be held until guidelines met .

Performance Compensation (Directors)

ElementMetricsPayout RangeNotes
Director RSUsNone (time-based)N/AAnnual RSU awards vest after one year; no performance metrics for director grants

Other Directorships & Interlocks

CompanyRoleInterlock/Conflict Notes
None disclosedNo other public company directorships disclosed; as a current DuPont executive, potential commercial overlaps would be reviewed under ASIX related-party and independence policies; 8-K indicates no Item 404(a) transactions at appointment .

Expertise & Qualifications

  • Deep operations, engineering, manufacturing, and HS&E expertise aligned with HS&E Committee oversight and broader board needs .
  • Regulatory and compliance experience from Arkema and DuPont roles .
  • Leadership credentials including military service; quote underscores commitment to operational excellence and collaborative governance .

Equity Ownership

HolderCommon SharesOther Stock-Based Holdings% of Outstanding
Daryl Roberts (Form 3 filed Sep 8, 2025)000.0% (26,807,818 shares outstanding as of Apr 1, 2025)
  • Insider trading, hedging, pledging: Company policy prohibits pledging, hedging, short sales, and options trading by directors .
  • Compliance timeline: Directors have five years to meet ownership guidelines .

Insider Trades

DateFilingDetails
Sep 8, 2025Form 3Initial statement of beneficial ownership filed; reports no beneficial ownership at appointment date 09/02/2025

Governance Assessment

  • Positive signals:

    • Independent appointment with immediate placement on C&LD and HS&E committees, aligning his operational and HS&E expertise to material risk oversight areas .
    • Strong governance framework: independent Chair, committee-only independent membership, robust related-party review, and prohibitions on hedging/pledging .
    • Director compensation mix balances cash and equity; increased 2025 equity grant supports alignment through stock ownership, with mandatory holding requirements until guidelines met .
  • Watch items / potential risks:

    • Current executive role at DuPont could present future supplier/customer/competitor interlocks; however, the Company discloses no related-party transactions at appointment and maintains formal review controls for any such situations .
    • Ownership alignment is nascent (Form 3 shows 0 shares); expected to build via annual RSUs and DCP, with five-year window to meet 5x retainer requirement .
  • RED FLAGS: None disclosed in filings at appointment (no Item 404(a) transactions, no family relationships, no arrangements/understandings) .